Affinivax is developing novel preventive and therapeutic vaccines based on its proprietary Multiple Antigen Presenting System (MAPS) technology platform. With an initial application to infectious diseases, MAPS offers a unique way to present key epitopes of multiple target antigens to induce a robust and broad immune response against a wide range of diseases.
Learn More ➤
Novel Vaccines Inducing a Broader and More Robust Immune Response
Affinivax is developing novel preventive and therapeutic vaccines based on its proprietary Multiple Antigen Presenting System (MAPS) technology platform. With an initial application to infectious diseases, MAPS offers a unique way to present key epitopes of multiple target antigens to induce a robust and broad immune response against a wide range of diseases.
Learn More ➤
Novel Vaccines Inducing a Broader and More Robust Immune Response
Our Mission to produce life-saving vaccines for people worldwide
